| Trial name or title | A Phase II Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease |
| Methods | |
| Participants | Alzheimer's dementia and mild cognitive impairment. Must be able to swallow pills. Must not have a known or suspected bipolar disorder |
| Interventions | Nutriceutical formulation |
| Outcomes | 1. Cognitive performance 2. Behavioural/psychotic symptoms |
| Starting date | August 2008 |
| Contact information | Contact: Ruth Remington, Ph.D. 978‐934‐4423 Ruth_remington@uml.edu Contact: Thomas B Shea, Ph.D. 978 934‐2881 thomas_shea@uml.edu |
| Notes | Not likely to be relevant to future reviews as it uses a Nutriceutical formulation |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.